マーケットレポート詳細
医療機器再処理の世界市場：タイプ別、用途別2027年予測
Medical Device Reprocessing Market by Type (Reprocessed Medical Devices), Device Category (Critical- Devices, Semi-Critical Devices, Non-Critical Devices), Application (Cardiology, Gynecology, Gastroenterology, Anesthesia) - Global Forecast to 2027
- 出版元：MarketsandMarkets
出版元について - 発行年：2022年7月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文173ページになります。
- 商品コード：MAM3016
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
医療機器再処理の世界市場規模2022年で20億ドル、2027年に39億ドル、市場の平均年成長率は13.7%に到達する見込みです。同市場の成長要因としては、病院の費用低減に対する必要性の高まり、高齢者人口の増加、シングルユース再処理医療機器の再利用に対する有利な規制認可、などが挙げられます。
レポートは医療機器再処理の世界市場について2027年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（タイプ別市場、機器タイプ別市場、等）を中心に構成されています。また競合状況、主要企業情報（11社）、エコシステム分析、ファイブフォース分析などの分析も加味し、医療機器再処理市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆医療機器再処理の世界市場予測2020-2027年
・市場規模(US$)
◆タイプ別、市場-2027年
・再処理サポート/サービス
・再処理医療機器
※(市場規模US$)
◆機器タイプ別、市場-2027年
・クリティカル機器
・セミクリティカル機器
・ノンクリティカル機器
※(市場規模US$)
◆用途別、市場-2027年
・心臓病学
・消化器病学
・関節鏡検査/整形外科
・婦人科
・一般外科
・その他用途
※(市場規模US$)
◆主要国地域別市場-2027年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、オーストラリア、中国、インド
・その他アジア太平洋
中南米
中東アフリカ
※国地域別に全セグメント別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス(ドライバー、障壁、機会、課題)
・ファイブフォース分析
・規制分析
・技術分析
・サプライチェーン分析
・エコシステム分析
・COVID-19の影響
・競合状況
◆医療機器再処理の主要企業プロフィール動向
・STRYKER CORPORATION
・JOHNSON & JOHNSON
・MEDTRONIC PLC
・STERIS HEALTHCARE
・CARDINAL HEALTH (SUSTAINABLE TECHNOLOGIES)
・ARJO GROUP (RENU MEDICAL, INC.)
・VANGUARD AG
・MEDLINE RENEWAL
・INNOVATIVE HEALTH
・STERIPRO CANADA, INC
・NORTHEAST SCIENTIFIC, INC.
（その他企業）
・SURETEK MEDICAL
・鴻池運輸株式会社
・AVANTE HEALTH SOLUTIONS
・MEDSALV
・VITRUVIA MEDICAL AG
（全173頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION 22
1.1 STUDY OBJECTIVES 22
1.2 MARKET DEFINITION AND SCOPE 22
1.2.1 INCLUSIONS AND EXCLUSIONS 22
1.2.2 MARKETS COVERED 23
・ FIGURE 1 MEDICAL DEVICE REPROCESSING MARKET SEGMENTATION 23
1.2.3 YEARS CONSIDERED 23
1.3 CURRENCY CONSIDERED 24
・ TABLE 1 USD EXCHANGE RATES CONSIDERED, 2018-2021 24
1.4 STAKEHOLDERS 24
1.5 SUMMARY OF CHANGES 24
2 RESEARCH METHODOLOGY 26
2.1 RESEARCH APPROACH 26
2.2 RESEARCH METHODOLOGY DESIGN 26
・ FIGURE 2 MEDICAL DEVICE REPROCESSING MARKET: RESEARCH DESIGN 26
2.2.1 SECONDARY DATA 27
2.2.1.1 KEY DATA FROM SECONDARY SOURCES 27
2.2.2 PRIMARY DATA 28
・ FIGURE 3 PRIMARY SOURCES 28
2.2.2.1 KEY DATA FROM PRIMARY SOURCES 29
2.2.2.2 INSIGHTS FROM PRIMARY EXPERTS 30
・ FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND
DEMAND SIDE PARTICIPANTS 30
・ FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 31
2.3 MARKET SIZE ESTIMATION 31
・ FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 32
・ FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION 32
・ FIGURE 8 TOP-DOWN APPROACH 33
・ FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 34
・ FIGURE 10 CAGR PROJECTIONS 35
2.4 DATA TRIANGULATION 36
・ FIGURE 11 DATA TRIANGULATION METHODOLOGY 36
2.5 MARKET SHARE ESTIMATION 37
2.6 RESEARCH ASSUMPTIONS 37
2.7 LIMITATIONS 37
2.7.1 METHODOLOGY-RELATED LIMITATIONS 37
2.7.2 SCOPE-RELATED LIMITATIONS 38
2.8 RISK ASSESSMENT 38
・ TABLE 2 RISK ASSESSMENT: MEDICAL DEVICE REPROCESSING MARKET 38
3 EXECUTIVE SUMMARY 39
・ FIGURE 12 MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 39
・ FIGURE 13 MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE,
2022 VS. 2027 (USD MILLION) 40
・ FIGURE 14 MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 40
・ FIGURE 15 GEOGRAPHICAL SNAPSHOT OF MEDICAL DEVICE REPROCESSING MARKET 41
4 PREMIUM INSIGHTS 43
4.1 BRIEF OVERVIEW OF MEDICAL DEVICE REPROCESSING MARKET 43
・ FIGURE 16 INCREASING NEED TO MINIMIZE MEDICAL WASTE AND REDUCE
HEALTHCARE COSTS TO DRIVE MARKET 43
4.2 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE AND COUNTRY (2021) 44
・ FIGURE 17 AUSTRALIA TO DOMINATE ASIA PACIFIC MEDICAL DEVICE REPROCESSING MARKET DURING FORECAST PERIOD 44
4.3 MEDICAL DEVICE REPROCESSING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 45
・ FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 45
4.4 MEDICAL DEVICE REPROCESSING MARKET, BY REGION (2020–2027) 46
・ FIGURE 19 NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD 46
4.5 MEDICAL DEVICE REPROCESSING MARKET: DEVELOPED VS. DEVELOPING MARKETS 46
・ FIGURE 20 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 46
5 MARKET OVERVIEW 47
5.1 INTRODUCTION 47
5.2 MARKET DYNAMICS 47
・ FIGURE 21 MEDICAL DEVICE REPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 47
5.2.1 DRIVERS 48
5.2.1.1 INCREASING LEVEL OF SUPPLY CHAIN COST SAVINGS IN HEALTHCARE FACILITIES 48
5.2.1.2 GROWING ADOPTION OF STRATEGIES FOR SUSTAINABILITY AND
ENVIRONMENTAL SAFETY 48
・ TABLE 3 EXAMPLES OF MARKET PLAYERS PROVIDING SUSTAINABILITY THROUGH REPROCESSING 49
5.2.1.3 RISING GERIATRIC POPULATION 49
・ FIGURE 22 GLOBAL GERIATRIC POPULATION (65 YEARS & ABOVE), BY REGION 50
・ TABLE 4 IMPACT ANALYSIS: MARKET DRIVERS 50
5.2.2 RESTRAINTS 50
5.2.2.1 INCREASING RISK OF HOSPITAL-ACQUIRED INFECTIONS AMONG PATIENTS 50
5.2.2.2 INCREASING NUMBER OF MEDICAL DEVICE SURFACE ALTERATIONS
DUE TO REPROCESSING 51
・ TABLE 5 IMPACT ANALYSIS: RESTRAINTS 51
5.2.3 OPPORTUNITIES 52
5.2.3.1 REGULATORY CHANGES FAVORING ADOPTION OF MEDICAL DEVICE REPROCESSING 52
5.2.3.2 GROWING OPPORTUNITIES AND FAVORABLE REGULATIONS IN
DEVELOPING COUNTRIES 52
・ TABLE 6 IMPACT ANALYSIS: OPPORTUNITIES 53
5.2.4 CHALLENGES 53
5.2.4.1 STRINGENT REGULATORY PROCEDURES FOR REPROCESSED MEDICAL DEVICES 53
・ TABLE 7 IMPACT ANALYSIS: CHALLENGES 53
5.3 KEY CONFERENCES AND EVENTS 54
・ TABLE 8 MEDICAL DEVICE REPROCESSING MARKET: DETAILED
LIST OF CONFERENCES AND EVENTS 54
5.4 INDUSTRY TRENDS 55
5.4.1 EXPANDING SERVICE PORTFOLIO AND MARKET REACH
THROUGH ACQUISITIONS 55
・ TABLE 9 MAJOR ACQUISITIONS IN MEDICAL DEVICE REPROCESSING MARKET 55
5.4.2 SPECIALTY REPROCESSING 55
5.5 PORTER’S FIVE FORCES ANALYSIS 56
・ TABLE 10 PORTER’S FIVE FORCES ANALYSIS 56
5.5.1 THREAT FROM NEW ENTRANTS 56
5.5.2 THREAT FROM SUBSTITUTES 57
5.5.3 BARGAINING POWER OF SUPPLIERS 57
5.5.4 BARGAINING POWER OF BUYERS 57
5.5.5 INTENSITY OF COMPETITIVE RIVALRY 58
5.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 58
・ TABLE 11 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 58
5.7 REGULATORY ANALYSIS 59
5.7.1 NORTH AMERICA 59
5.7.1.1 US 59
・ FIGURE 23 PREMARKET NOTIFICATION: 510 (K) APPROVAL FOR REPROCESSED MEDICAL DEVICES 59
5.7.1.2 CANADA 60
5.7.2 EUROPE 60
・ TABLE 12 EU COUNTRIES AND THEIR TERRITORY LAWS THAT AUTHORIZE SINGLE-USE DEVICE REPROCESSING 61
5.7.3 ASIA PACIFIC 61
5.7.3.1 JAPAN 61
5.7.3.2 AUSTRALIA 61
5.7.3.3 REST OF ASIA PACIFIC 62
・ TABLE 13 INTERNATIONAL STANDARDS FOR MEDICAL DEVICE REPROCESSING 62
5.8 TECHNOLOGY ANALYSIS 62
・ TABLE 14 TECHNOLOGY AND INNOVATION IN MEDICAL DEVICE
REPROCESSING MARKET 62
5.9 SUPPLY CHAIN ANALYSIS 63
・ FIGURE 24 SUPPLY CHAIN: MEDICAL DEVICE REPROCESSING MARKET 64
5.10 ECOSYSTEM ANALYSIS 64
・ FIGURE 25 MEDICAL DEVICE REPROCESSING MARKET: ECOSYSTEM ANALYSIS 64
5.11 MEDICAL DEVICE REPROCESSING MARKET: PATENT ANALYSIS 65
5.11.1 PATENT PUBLICATION TRENDS FOR MEDICAL DEVICE REPROCESSING 65
・ FIGURE 26 PATENT PUBLICATION TRENDS (2011–JULY 2022) 65
5.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 65
・ FIGURE 27 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR MEDICAL DEVICE REPROCESSING (JANUARY 2011–JULY 2022) 66
・ FIGURE 28 TOP APPLICANT JURISDICTIONS FOR MEDICAL DEVICE REPROCESSING PATENTS (JANUARY 2011–JULY 2022) 67
・ TABLE 15 LIST OF PATENTS/PATENT APPLICATIONS IN MEDICAL DEVICE REPROCESSING MARKET, 2021–2022 67
5.12 IMPACT OF COVID-19 ON MEDICAL DEVICE REPROCESSING MARKET 68
6 MEDICAL DEVICE REPROCESSING MARKET, BY TYPE 69
6.1 INTRODUCTION 70
・ TABLE 16 MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 70
6.2 REPROCESSING SUPPORT AND SERVICES 70
6.2.1 REDUCING IN-HOUSE REPROCESSING COSTS AND INCREASING REGULATORY MANDATES TO DRIVE MARKET 70
・ TABLE 17 REPROCESSING SUPPORT AND SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 71
6.3 REPROCESSED MEDICAL DEVICES 71
6.3.1 INCREASING ADOPTION OF REPROCESSED DEVICES AT LOWER
COSTS TO DRIVE MARKET 71
・ TABLE 18 REPROCESSED MEDICAL DEVICES OFFERED BY KEY MARKET PLAYERS 72
・ TABLE 19 REPROCESSED MEDICAL DEVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 74
7 MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE 75
7.1 INTRODUCTION 76
・ TABLE 20 MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE,
2020–2027 (USD MILLION) 76
7.2 CRITICAL DEVICES 76
7.2.1 HIGH COST OF BUYING NEW DEVICES TO DRIVE MARKET 76
・ TABLE 21 REPROCESSED CRITICAL MEDICAL DEVICE CATEGORY 77
・ TABLE 22 CRITICAL DEVICES REPROCESSING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 78
7.3 SEMI-CRITICAL DEVICES 78
7.3.1 INCREASED CASES OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET 78
・ TABLE 23 SEMI-CRITICAL DEVICE REPROCESSING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 79
7.4 NON-CRITICAL DEVICES 79
7.4.1 INCREASING MEDICAL PROCEDURES AND SURGERIES TO DRIVE MARKET 79
・ TABLE 24 NON-CRITICAL DEVICE REPROCESSING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 80
8 MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION 81
8.1 INTRODUCTION 82
・ TABLE 25 MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 82
8.2 CARDIOLOGY 82
8.2.1 RISING CORONARY ARTERY DISEASE CASES TO PROPEL MARKET 82
・ TABLE 26 MEDICAL DEVICE REPROCESSING MARKET FOR CARDIOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 83
8.3 GASTROENTEROLOGY 84
8.3.1 INCREASING USE OF ENDOSCOPES FOR DISEASE DIAGNOSIS
TO DRIVE MARKET 84
・ TABLE 27 MEDICAL DEVICE REPROCESSING MARKET FOR GASTROENTEROLOGY,
BY COUNTRY, 2020–2027 (USD MILLION) 84
8.4 ARTHROSCOPY AND ORTHOPEDIC SURGERY 85
8.4.1 REGULATORY INITIATIVES AND COST REDUCTION TO DRIVE MARKET 85
・ TABLE 28 APPROVED ORTHOPEDIC/ARTHROSCOPIC DEVICES FOR REPROCESSING 85
・ TABLE 29 MEDICAL DEVICE REPROCESSING MARKET FOR ARTHROSCOPY AND ORTHOPEDIC SURGERY, BY COUNTRY, 2020–2027 (USD MILLION) 86
8.5 GYNECOLOGY 86
8.5.1 INCREASING GYNECOLOGY PROCEDURES TO DRIVE MARKET 86
・ TABLE 30 MEDICAL DEVICE REPROCESSING MARKET FOR GYNECOLOGY,
BY COUNTRY, 2020–2027 (USD MILLION) 87
8.6 GENERAL SURGERY 87
8.6.1 LOW-COST GENERAL SURGERY DEVICES TO IMPACT MARKET 87
・ TABLE 31 MEDICAL DEVICE REPROCESSING MARKET FOR GENERAL SURGERIES,
BY COUNTRY, 2020–2027 (USD MILLION) 88
8.7 OTHER APPLICATIONS 88
・ TABLE 32 MEDICAL DEVICE REPROCESSING MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 89
9 MEDICAL DEVICE REPROCESSING MARKET, BY REGION 90
9.1 INTRODUCTION 91
・ FIGURE 29 MEDICAL DEVICE REPROCESSING MARKET: GEOGRAPHIC SNAPSHOT (2021) 91
・ TABLE 33 MEDICAL DEVICE REPROCESSING MARKET, BY REGION,
2020–2027 (USD MILLION) 92
9.2 NORTH AMERICA 92
・ FIGURE 30 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET SNAPSHOT 93
・ TABLE 34 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 93
・ TABLE 35 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION) 94
・ TABLE 36 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 94
・ TABLE 37 NORTH AMERICA: MEDICAL DEVICE REPROCESSING MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 94
9.2.1 US 95
9.2.1.1 PRESENCE OF MAJOR PLAYERS AND HEALTHCARE COST REDUCTION STRATEGIES TO DRIVE MARKET 95
・ FIGURE 31 US: TOTAL NUMBER OF HOSPITALS 95
・ TABLE 38 US: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 96
・ TABLE 39 US: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE,
2020–2027 (USD MILLION) 96
・ TABLE 40 US: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 96
9.2.2 CANADA 97
9.2.2.1 GROWING GERIATRIC POPULATION AND INCREASING CHRONIC DISEASES
TO DRIVE MARKET 97
・ TABLE 41 CANADA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 97
・ TABLE 42 CANADA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 98
・ TABLE 43 CANADA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 98
9.3 EUROPE 98
・ TABLE 44 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 99
・ TABLE 45 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 99
・ TABLE 46 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 100
・ TABLE 47 EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 100
9.3.1 GERMANY 100
9.3.1.1 GOVERNMENT INITIATIVES AND WELL-ESTABLISHED STANDARDS TO
DRIVE MARKET 100
・ TABLE 48 GERMANY: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 101
・ TABLE 49 GERMANY: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 101
・ TABLE 50 GERMANY: MEDICAL DEVICE REPROCESSING MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 102
9.3.2 UK 102
9.3.2.1 INCREASING HOSPITAL ADMISSIONS TO DRIVE MARKET 102
・ TABLE 51 UK: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 103
・ TABLE 52 UK: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE,
2020–2027 (USD MILLION) 103
・ TABLE 53 UK: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 103
9.3.3 FRANCE 104
9.3.3.1 GROWING DIAGNOSTIC MEDICAL DEVICE MARKET WITH RISING CHRONIC DISEASES TO PROPEL MARKET 104
・ TABLE 54 FRANCE: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 104
・ TABLE 55 FRANCE: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 105
・ TABLE 56 FRANCE: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 105
9.3.4 ITALY 105
9.3.4.1 INCREASING USE OF DIAGNOSTIC DEVICES AND GOVERNMENT INITIATIVES TO DRIVE MARKET 105
・ TABLE 57 ITALY: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 106
・ TABLE 58 ITALY: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE,
2020–2027 (USD MILLION) 106
・ TABLE 59 ITALY: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 107
9.3.5 SPAIN 107
9.3.5.1 INCREASING FOCUS ON REDUCING HOSPITAL COSTS TO DRIVE MARKET 107
・ TABLE 60 SPAIN: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 108
・ TABLE 61 SPAIN: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE,
2020–2027 (USD MILLION) 108
・ TABLE 62 SPAIN: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 108
9.3.6 REST OF EUROPE 109
・ TABLE 63 REST OF EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION) 109
・ TABLE 64 REST OF EUROPE: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 110
・ TABLE 65 REST OF EUROPE: MEDICAL DEVICE REPROCESSING MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 110
9.4 ASIA PACIFIC 110
・ FIGURE 32 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET SNAPSHOT 111
・ TABLE 66 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 112
・ TABLE 67 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 112
・ TABLE 68 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET,
BY DEVICE TYPE, 2020–2027 (USD MILLION) 112
・ TABLE 69 ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 113
9.4.1 AUSTRALIA 113
9.4.1.1 GROWING ADOPTION OF MEDICAL DEVICES FOR DIAGNOSIS AND TREATMENT TO DRIVE MARKET 113
・ TABLE 70 AUSTRALIA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 114
・ TABLE 71 AUSTRALIA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 114
・ TABLE 72 AUSTRALIA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 115
9.4.2 JAPAN 115
9.4.2.1 REGULATORY REFORMS AND NEED TO REDUCE HOSPITAL COSTS TO DRIVE MARKET 115
・ TABLE 73 JAPAN: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
・ TABLE 74 JAPAN: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE,
2020–2027 (USD MILLION) 116
・ TABLE 75 JAPAN: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 116
9.4.3 CHINA 117
9.4.3.1 GOVERNMENT INITIATIVES AND DEVELOPING ECONOMY TO DRIVE MARKET 117
・ TABLE 76 CHINA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 117
・ TABLE 77 CHINA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE,
2020–2027 (USD MILLION) 118
・ TABLE 78 CHINA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 118
9.4.4 INDIA 118
9.4.4.1 GOVERNMENT INITIATIVES FOR DIAGNOSIS AND TREATMENT TO DRIVE MARKET 118
・ TABLE 79 INDIA: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE,
2020–2027 (USD MILLION) 119
・ TABLE 80 INDIA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE
2020–2027 (USD MILLION) 119
・ TABLE 81 INDIA: MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 120
9.4.5 REST OF ASIA PACIFIC 120
・ TABLE 82 REST OF ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
・ TABLE 83 REST OF ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET,
BY DEVICE TYPE, 2020–2027 (USD MILLION) 121
・ TABLE 84 REST OF ASIA PACIFIC: MEDICAL DEVICE REPROCESSING MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 121
9.5 LATIN AMERICA 122
9.5.1 INCREASING CHRONIC DISEASES AND ADOPTION OF MEDICAL DEVICES TO DRIVE MARKET 122
・ TABLE 85 LATIN AMERICA: MEDICAL DEVICE REPROCESSING MARKET,
BY TYPE, 2020–2027 (USD MILLION) 122
・ TABLE 86 LATIN AMERICA: MEDICAL DEVICE REPROCESSING MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 123
・ TABLE 87 LATIN AMERICA: MEDICAL DEVICE REPROCESSING MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 123
9.6 MIDDLE EAST & AFRICA 124
9.6.1 EMERGENCE OF REGULATORY FRAMEWORKS TO DRIVE MARKET 124
・ TABLE 88 MIDDLE EAST & AFRICA: MEDICAL DEVICE REPROCESSING MARKET,
BY TYPE, 2020–2027 (USD MILLION) 124
・ TABLE 89 MIDDLE EAST & AFRICA: MEDICAL DEVICE REPROCESSING MARKET,
BY DEVICE TYPE, 2020–2027 (USD MILLION) 125
・ TABLE 90 MIDDLE EAST & AFRICA: MEDICAL DEVICE REPROCESSING MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 125
10 COMPETITIVE LANDSCAPE 126
10.1 OVERVIEW 126
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 126
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL
DEVICE REPROCESSING MARKET 126
10.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS 127
・ FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL DEVICE
REPROCESSING MARKET 128
10.4 MARKET SHARE ANALYSIS, 2021 128
・ FIGURE 34 MEDICAL DEVICE REPROCESSING MARKET SHARES, BY KEY PLAYER, 2021 129
・ TABLE 91 MEDICAL DEVICE REPROCESSING MARKET: DEGREE OF COMPETITION 129
10.5 COMPETITIVE BENCHMARKING 130
・ TABLE 92 MEDICAL DEVICE REPROCESSING MARKET: DETAILED LIST OF SMALL AND MEDIUM PLAYERS 130
10.6 COMPANY FOOTPRINT 131
・ TABLE 93 FOOTPRINT OF COMPANIES IN MEDICAL DEVICE REPROCESSING MARKET 131
・ TABLE 94 SERVICE FOOTPRINT OF COMPANIES (16 COMPANIES) 132
・ TABLE 95 APPLICATION FOOTPRINT OF COMPANIES (16 COMPANIES) 133
・ TABLE 96 REGIONAL FOOTPRINT OF COMPANIES (16 COMPANIES) 134
10.7 COMPANY EVALUATION QUADRANT 134
10.7.1 STARS 135
10.7.2 EMERGING LEADERS 135
10.7.3 PERVASIVE PLAYERS 135
10.7.4 PARTICIPANTS 135
・ FIGURE 35 MEDICAL DEVICE REPROCESSING MARKET: COMPANY EVALUATION QUADRANT (2021) 136
10.8 COMPETITIVE SCENARIO 137
10.8.1 FDA APPROVALS/SERVICE ENHANCEMENTS 137
10.8.2 DEALS 138
10.8.3 OTHER DEVELOPMENTS 138
11 COMPANY PROFILES 140
11.1 KEY PLAYERS 140
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
11.1.1 STRYKER CORPORATION 140
・ TABLE 100 STRYKER CORPORATION: COMPANY OVERVIEW 140
・ FIGURE 36 STRYKER CORPORATION: COMPANY SNAPSHOT (2021) 141
11.1.2 JOHNSON & JOHNSON 143
・ TABLE 101 JOHNSON & JOHNSON: COMPANY OVERVIEW 143
・ FIGURE 37 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2021) 144
11.1.3 MEDTRONIC PLC 146
・ TABLE 102 MEDTRONIC PLC: COMPANY OVERVIEW 146
・ FIGURE 38 MEDTRONIC PLC: COMPANY SNAPSHOT (2021) 147
11.1.4 STERIS HEALTHCARE 149
・ TABLE 103 STERIS HEALTHCARE: COMPANY OVERVIEW 149
・ FIGURE 39 STERIS HEALTHCARE: COMPANY SNAPSHOT (2021) 150
11.1.5 CARDINAL HEALTH (SUSTAINABLE TECHNOLOGIES) 152
・ TABLE 104 CARDINAL HEALTH: COMPANY OVERVIEW 152
・ FIGURE 40 CARDINAL HEALTH: COMPANY SNAPSHOT (2021) 153
11.1.6 ARJO GROUP (RENU MEDICAL, INC.) 154
・ TABLE 105 ARJO GROUP: COMPANY OVERVIEW 154
・ FIGURE 41 ARJO GROUP: COMPANY SNAPSHOT (2021) 155
11.1.7 VANGUARD AG 156
・ TABLE 106 VANGUARD AG: COMPANY OVERVIEW 156
11.1.8 MEDLINE RENEWAL 157
・ TABLE 107 MEDLINE RENEWAL: COMPANY OVERVIEW 157
11.1.9 INNOVATIVE HEALTH 159
・ TABLE 108 INNOVATIVE HEALTH: COMPANY OVERVIEW 159
11.1.10 STERIPRO CANADA, INC 161
・ TABLE 109 STERIPRO CANADA, INC.: COMPANY OVERVIEW 161
11.1.11 NORTHEAST SCIENTIFIC, INC. 162
・ TABLE 110 NE SCIENTIFIC, INC.: COMPANY OVERVIEW 162
11.2 OTHER PLAYERS 164
11.2.1 SURETEK MEDICAL 164
11.2.2 KONOIKE GROUP 165
11.2.3 AVANTE HEALTH SOLUTIONS 166
11.2.4 MEDSALV 167
11.2.5 VITRUVIA MEDICAL AG 168
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
12 APPENDIX 169